Literature DB >> 14325336

THE EFFECTS OF SOME ARALKYLGUANIDINES IN MICE.

R FIELDEN, A L GREEN.   

Abstract

Keywords:  DOPAMINE; EXPERIMENTAL LAB STUDY; EYELIDS; GUANETHIDINE; GUANIDINES; HEART; INJECTIONS, SUBCUTANEOUS; MICE; MONOAMINE OXIDASE INHIBITORS; NOREPINEPHRINE; OXIDOREDUCTASES; SYMPATHOLYTICS

Mesh：

Substances：

Year:  1965        PMID： 14325336      PMCID： PMC1704123          DOI： 10.1111/j.1476-5381.1965.tb01728.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  15 in total

1.  SOME NEW ADRENERGIC NEURONE BLOCKING AGENTS.

Authors:  J AUGSTEIN; S M GREEN
Journal:  Nature       Date:  1964-02-08       Impact factor: 49.962

2.  POTENTIAL ANTIHYPERTENSIVE AGENTS. SOME GUANIDINE DERIVATIVES.

Authors:  D I BARRON; P M BAVIN; G J DURANT; I L NATOFF; R G SPICKETT; D K VALLANCE
Journal:  J Med Chem       Date:  1963-11       Impact factor: 7.446

3.  A MODIFICATION OF THE BUTANOL EXTRACTION METHOD FOR THE FLUORIMETRIC ASSAY OF CATECHOLAMINES IN BIOLOGICAL MATERIALS.

Authors:  B A CALLINGHAM; R CASS
Journal:  J Pharm Pharmacol       Date:  1963-10       Impact factor: 3.765

4.  MONOAMINE OXIDASE INHIBITION BY A SERIES OF COMPOUNDS STRUCTURALLY RELATED TO BRETYLIUM AND GUANETHIDINE.

Authors:  R KUNTZMAN; M M JACOBSON
Journal:  J Pharmacol Exp Ther       Date:  1963-08       Impact factor: 4.030

5.  On the mechanism of inhibition of dopamine-beta-oxidase by benzyloxyamines.

Authors:  J VAN DER SCHOOT; C R CREVELING; T NAGATSU; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1963-07       Impact factor: 4.030

6.  The inhibition of monoamine oxidase by arylalkylhydrazines.

Authors:  A L GREEN
Journal:  Biochem J       Date:  1962-07       Impact factor: 3.857

7.  A colorimetric method for the estimation of monoamine oxidase.

Authors:  A L GREEN; T M HAUGHTON
Journal:  Biochem J       Date:  1961-01       Impact factor: 3.857

8.  Bioassay of Rauwolfia roots and alkaloids.

Authors:  B RUBIN; M H MALONE; M H WAUGH; J C BURKE
Journal:  J Pharmacol Exp Ther       Date:  1957-06       Impact factor: 4.030

9.  In-vitro formation of noradrenaline from dopamine by human tissue.

Authors:  W A BAIN; R FIELDEN
Journal:  Lancet       Date:  1957-09-07       Impact factor: 79.321

10.  Action of TM 10 (choline 2: 6-xylyl ether bromide) and its beta-methyl derivative on the conversion of dopamine to noradrenaline by chromaffin tissue.

Authors:  P B HAGEN; E ZEBROWSKI
Journal:  Biochem Pharmacol       Date:  1962-03       Impact factor: 5.858
View more
  5 in total

1.  Optical isomers of beta-hydroxyphenethylguanidine: effects on heart noradrenaline and on sympathetic blockade.

Authors:  R Fielden; A L Green
Journal:  Br J Pharmacol Chemother       Date:  1968-02

2.  Studies on the antagonism between the optical isomers of N-(1-phenylethyl)guanidine.

Authors:  R Fielden; A L Green
Journal:  Br J Pharmacol Chemother       Date:  1966-01

3.  A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-beta-hydroxyphenethylguanidine.

Authors:  R Fielden; A L Green
Journal:  Br J Pharmacol Chemother       Date:  1967-05

4.  [18F]Fluoro-Hydroxyphenethylguanidines: Efficient Synthesis and Comparison of Two Structural Isomers as Radiotracers of Cardiac Sympathetic Innervation.

Authors:  Yong-Woon Jung; Keun Sam Jang; Guie Gu; Robert A Koeppe; Phillip S Sherman; Carole A Quesada; David M Raffel
Journal:  ACS Chem Neurosci       Date:  2017-03-27       Impact factor: 4.418

5.  Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors.

Authors:  David M Raffel; Yong-Woon Jung; David L Gildersleeve; Phillip S Sherman; James J Moskwa; Louis J Tluczek; Wei Chen
Journal:  J Med Chem       Date:  2007-04-10       Impact factor: 7.446
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.